MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.

Cao Y, Qiu Y, Liu MX, Hu Y, Chen FW.

Open source

DOI
10.26355/eurrev_202101_24625
Published
2021-01-01
Container
Eur Rev Med Pharmacol Sci
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_202101_24625,
  title = {MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.},
  author = {Cao Y and  Qiu Y and  Liu MX and  Hu Y and  Chen FW.},
  year = {2021},
  journal = {Eur Rev Med Pharmacol Sci},
  doi = {10.26355/eurrev_202101_24625},
  url = {https://doi.org/10.26355/eurrev_202101_24625}
}

RIS

TY  - JOUR
TI  - MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.
AU  - Cao Y
AU  -  Qiu Y
AU  -  Liu MX
AU  -  Hu Y
AU  -  Chen FW.
PY  - 2021
JO  - Eur Rev Med Pharmacol Sci
DO  - 10.26355/eurrev_202101_24625
UR  - https://doi.org/10.26355/eurrev_202101_24625
ER  - 

APA

Y, C., Y, Q., MX, L., Y, H., & FW., C. (2021). MiR-29c-3p reduces bone loss in rats with diabetic osteoporosis via targeted regulation of Dvl2 expression.. Eur Rev Med Pharmacol Sci. https://doi.org/10.26355/eurrev_202101_24625

Source records